| Sharon A Sandberg, MD | |
|
Henry Ford Health System, 2799 West Grand Boulevard, Detroit, MI 48202 | |
| (313) 916-2436 | |
| Not Available |
| Full Name | Sharon A Sandberg |
|---|---|
| Gender | Female |
| Speciality | Radiology - Diagnostic Radiology |
| Location | Henry Ford Health System, Detroit, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477621118 | NPI | - | NPPES |
| SS052902 | Other | COMMERCIAL-COMMERCIAL NUMBER | |
| SS052902 | Other | CHAMPUS-CHAMPUS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 4301052902 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sharon A Sandberg, MD Henry Ford Health System, 2799 West Grand Boulevard, Detroit, MI 48202 Ph: (313) 916-2436 | Sharon A Sandberg, MD Henry Ford Health System, 2799 West Grand Boulevard, Detroit, MI 48202 Ph: (313) 916-2436 |
News Archive
In a major step to treat patients living with Myelodysplastic Syndromes (MDS), a group of diseases that affect the bone marrow and blood, Moffitt Cancer Center today announced the development of an innovative investigational biologic agent that could improve patient response and outcomes for MDS and other diseases.
Researchers at The University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center in Phoenix have discovered that many women with low-grade serous carcinoma of the ovary or peritoneum have seen their tumors stabilize or shrink after taking a regular dose of the compound selumetinib.
As many as half of people infected with viral hepatitis have suffered discrimination and one-quarter admit that family members have avoided physical contact with them after finding out they had the infection. A shocking patient survey presented at The International Liver Congress 2015 has shown the devastating impact the infection has on their daily lives.
Genentech, a member of the Roche Group, today announced that BRIM3, a Phase III clinical study of RG7204, met its co-primary endpoints showing a significant survival benefit in people with previously untreated BRAF V600 mutation-positive metastatic melanoma.
It sounds like hype from a late-night infomercial: It can twist and bend without breaking! And wait, there's more: It could someday help you fend off disease!
› Verified 1 days ago
Dr. Brent David Griffith, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 | |
Kanika Khanna, M.D Radiology Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 | |
Dr. Michael Matthew Dominello, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 4100 John R, Detroit, MI 48201 Phone: 800-527-6266 Fax: 313-576-9640 | |
Rajinder P. Sharma, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: Henry Ford Health System, 2799 West Grand Boulevard, Detroit, MI 48202 Phone: 313-916-2436 | |
Milan V. Pantelic, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Henry Ford Health System, 2799 West Grand Boulevard, Detroit, MI 48202 Phone: 313-916-2436 | |
Kristan Gail Jenkins-mosure, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 800-653-6568 | |
Kristin Booth, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 517-402-1383 |